Understanding prescription adherence: Pharmacy claims data from the Contraceptive CHOICE Project

Contraception

Volumn 83, Issue 4, 2011, Pages 340-345

  Pittman, Meredith E ^a   Secura, Gina M ^a   Allsworth, Jenifer E ^a   Homco, Juell B ^a   Madden, Tessa ^a   Peipert, Jeffrey F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pharmacy claims data; Prescription adherence; Unintended pregnancy; Vaginal ring

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ABORTION; ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; RISK FACTOR; TRANSDERMAL PATCH; VAGINA RING;

ADOLESCENT; ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE DEVICES, FEMALE; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; LONGITUDINAL STUDIES; MEDICATION ADHERENCE; MIDDLE AGED; MISSOURI; PHARMACY; REGRESSION ANALYSIS; TRANSDERMAL PATCH; YOUNG ADULT;

EID: 79952575360     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.08.003     Document Type: Article

References (34)

1. Hughes DA, Bagust A, Haycox A, Walley T. The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ 2001;10:601-15. (Pubitemid 32998372)
2. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-77. (Pubitemid 32466236)
3. Recker RR, Gallagher R, MacCosbe PE. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 2005;80:856-61. (Pubitemid 40911458)
4. Grimes DA. Forgettable contraception. Contraception 2009;80:497-9.
5. Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 2006;28:1411-24 [discussion 1410].
6. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-16. (Pubitemid 27089212)
7. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2006;38:922-8. (Pubitemid 44498580)
8. Nettleman MD, Chung H, Brewer J, Ayoola A, Reed PL. Reasons for unprotected intercourse: analysis of the PRAMS survey. Contraception 2007;75:361-6. (Pubitemid 46551075)
9. Cates Jr W. Contraception, unintended pregnancies, and sexually transmitted diseases: why isn't a simple solution possible? Am J Epidemiol 1996;143:311-8.
10. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006; 38:90-6.
11. Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 2008;77:10-21.
12. Rosenberg M, Waugh MS. Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 1999;180(Pt 2): 276-9.
13. Gilliam ML, Neustadt A, Kozloski M, Mistretta S, Tilmon S, Godfrey E. Adherence and acceptability of the contraceptive ring compared with the pill among students. Obstet Gynecol 2010;115:503-10.
14. Wetzels GE, Nelemans PJ, Schouten JS, van Wijk BL, Prins MH. All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions - an observational study. BMC Health Serv Res 2006;6:8.
15. Curtis JR, Xi J, Westfall AO, et al. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care 2009;47:334-41.
16. Frost JJ, Darroch JE. Factors associated with contraceptive choice and inconsistent method use, United States, 2004. Perspect Sex Reprod Health 2008;40:94-104.
17. Nelson AL, Westhoff C, Schnare SM. Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation. Obstet Gynecol 2008;112:782-7.
18. Secura GM, Allsworth JE, Madden T, Hladky KJ, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010;203: 115.e1-7 [Epub 2010 Jun 11].
19. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005;11:449-57. (Pubitemid 41022729)
20. Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 2007;82:1493-501. (Pubitemid 350211697)
21. Matteson KA, Peipert JF, Allsworth J, Phipps MG, Redding CA. Unplanned pregnancy: does past experience influence the use of a contraceptive method? Obstet Gynecol 2006;107:121-7.
22. Pilon D, Castilloux AM, LeLorier J. Estrogen replacement therapy: determinants of persistence with treatment. Obstet Gynecol 2001;97: 97-100. (Pubitemid 32057165)
23. Ranjit N, Bankole A, Darroch JE, Singh S. Contraceptive failure in the first two years of use: differences across socioeconomic subgroups. Fam Plann Perspect 2001;33:19-27.
24. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-6. (Pubitemid 38405384)
25. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Faculty statement from the CEU on a new publication: WHO Selected Practice Recommendations for Contraceptive Use Update. Missed pills: new recommendations. J Fam Plann Reprod Health Care 2005;31:153-5.
26. Foster DG, Parvataneni R, de Bocanegra HT, Lewis C, Bradsberry M, Darney P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet Gynecol 2006; 108:1107-14. (Pubitemid 44665404)
27. Westhoff CL, Heartwell S, Edwards S, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol 2007; 196:412.e1-7.
28. Frost JJ, Darroch JE, Remez L. Improving contraceptive use in the United States. Issues Brief (Alan Guttmacher Inst) 2008:1-8.
29. Phillips SD, Imhoff AR. Women and career development: a decade of research. Ann Rev Psychol 1997;48:31-59. (Pubitemid 127485169)
30. Homco JB, Peipert JF, Secura GM, Lewis VA, Allsworth JE. Reasons for ineffective pre-pregnancy contraception use in patients seeking abortion services. Contraception 2009;80:569-74.
31. Curkendall S, Patel V, Gleeson M, Campbell RS, Zagari M, Dubois R. Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter? Arthritis Rheum 2008;59: 1519-26.
32. Kennedy J, Coyne J, Sclar D. Drug affordability and prescription noncompliance in the United States: 1997-2002. Clin Ther 2004;26: 607-14.
33. Roughead EE, Ramsay E, Priess K, Barratt J, Ryan P, Gilbert AL. Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates. Pharmacoepidemiol Drug Saf 2009;18:69-75.
34. Steiner JF. Can we identify clinical predictors of medication adherence....and should we? Med Care 2010;48:193-5.